ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Presence of AT1R Antibody Pre-Transplant Does Not Correlate with Rejection in a Large Pediatric Kidney Transplant Cohort

    K. Hitchman1, P. K. Shah1, D. Fritze1, R. Hinojosa2, D. Ranch1

    1University Health Transplant Institute, San Antonio, TX, 2Pharmacy, University Health Transplant Institute, San Antonio, TX

    *Purpose: Describe correlations between pre-transplant (PreTXP) presence of anti-angiotensin II receptor type 1 antibodies (AT1RAb) and post-transplant (PostTXP) outcomes in a pediatric kidney transplant (PKT)…
  • 2022 American Transplant Congress

    The Role of HNF4α in Renal Ischemia Reperfusion Injury

    A. D. Saha

    Toronto General Hospital Research Institute, Toronto, ON, Canada

    *Purpose: Ischemia reperfusion injury (IRI) affects all solid organ transplants and impairs renal graft function. However, the mechanisms by which IRI affects grafts are incompletely…
  • 2022 American Transplant Congress

    Early Post-Operative Thrombotic Microangiopathy in Deceased Donor Kidney Transplant: A Retrospective Case Series

    R. Seneriz1, A. Mattiazzi1, G. Guerra1, T. Harrington2, M. Velasquez3

    1Miami Transplant Institute, Miami, FL, 2University of Miami, Miami, FL, 3Jackson Memorial Hospital, Miami, FL

    *Purpose: Transplant associated thrombotic microangiopathy (TA-TMA) is characterized by endothelial injury along with thrombocytopenia, microangiopathic hemolytic anemia (MAHA) and kidney graft dysfunction. It can be…
  • 2022 American Transplant Congress

    Impact of Total Parenteral Nutrition on Donor Kidneys During Oxygenated Preservation at 22ºC Ex Vivo

    P. Luke1, A. Jackson2, A. Ruthirakanthan2, S. Juriasingani2, M. Levine1, L. Jiang2, R. Patel2, M. Richard-Mohamed1, S. Forrest1, A. Sener1, R. N. Bhattacharjee1

    1London Health Sciences Centre, London, ON, Canada, 2Western University, London, ON, Canada

    *Purpose: Recent studies have shown that ex vivo preservation at 37 º C can reduce kidney injury compared to current clinical practice. However, to mitigate…
  • 2022 American Transplant Congress

    Outcomes After Kidney Transplantation in Post Bariatric Surgery Patients: Systematic Review 

    N. Pencovici1, J. Long1, M. Stegall2, A. Kukla1, T. Diwan1

    1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic, Rochester, MN

    *Purpose: Morbid obesity is a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes. Bariatric surgery (BS) is increasingly performed in…
  • 2022 American Transplant Congress

    Waitlist Meldna Variation One-year Prior To Liver Transplant Predicts Length Of Stay At The Time Of Transplant

    L. Pruinelli1, S. Olson1, J. Zhou1, M. Nguyen1, J. Schold2, T. Pruett1, S. Ma1, G. Simon1

    1University of Minnesota, Minneapolis, MN, 2Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: MELDNa is used to estimate 90-day mortality in the waitlist. MELDNa variation between cross-sections has shown a better predictivity than when analyzed as a…
  • 2022 American Transplant Congress

    Transplant Rates Increased with Broader Distribution of Deceased Donor Kidneys

    A. Robinson1, K. Gauntt1, A. Wilk1, J. Kim2, V. Casingal3, N. Turgeon4, M. Pavlakis5

    1UNOS, Richmond, VA, 2Surgery, Keck Medicine of USC, Los Angeles, CA, 3Carolinas Medical Center, Charlotte, NC, 4Dell Seton Medical Center at The University of Texas, Austin, TX, 5Beth Israel Deaconess Med Ctr, Boston, MA

    *Purpose: The OPTN Kidney Transplantation Committee implemented a policy removing donation service area (DSA) and OPTN region from kidney allocation on 3/15/2021. In addition to…
  • 2022 American Transplant Congress

    Barriers and Facilitators to Care for Patients with Failed Kidney Transplants

    A. Huml1, K. Berg2, A. Perzynski2, C. Sullivan2, A. Sehgal2

    1Department of Kidney Medicine, Cleveland Clinic, Cleveland, OH, 2Population Health Research Institute, The MetroHealth System, Cleveland, OH

    *Purpose: To understand the barriers and facilitators to care for patients with failed kidney transplants from the perspective of providers.*Methods: Qualitative study employed focus groups…
  • 2022 American Transplant Congress

    Role of Circulating Tumour Cells in the Management of the Liver Transplant Patient with Hepatocellular Carcinoma

    F. Villalba1, F. Alconchel2, L. Sáenz3, M. Sánchez-Lorencio1, D. Ferreras2, P. Cascales2, F. Sánchez-Bueno2, R. Robles2, P. Ramírez2

    1IMIB-Virgen de la Arrixaca, Murcia, Spain, 2Surgery and Organ Transplantation, Virgen de la Arrixaca University Hospital (IMIB-Virgen de la Arrixaca), Murcia, Spain, 3Rafael Méndez Hospital, Lorca, Spain

    *Purpose: For hepatocellular carcinoma (HCC), liver transplantation (LT) is considered a curative treatment, however, more than 10% of transplant recipients have recurrences within the first…
  • 2022 American Transplant Congress

    Combined CyTOF and Elispot Investigation of CMV Response Over the First Year Post Kidney Transplantation

    T. Jouve1, L. Donadeu Casassas2, S. Hartzell3, E. Crespo2, M. Meneghini2, A. Torija2, P. Cravedi4, O. Bestard2

    1Nephrology, Vall d’Hebron Institut de Recerca (VHIR), Grenoble, Spain, 2Nephrology, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, 3Mount Sinai Hospital, New York, NY, 4Mount Sinai, New York, NY

    *Purpose: CMV remains a threat for kidney transplant recipients (KTR). Deciphering the impact of CMV on the immune system of KTR has helped improving CMV…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences